Novel multiplex allele-specific PCR assays for the detection of resistance to second-line drugs in Mycobacterium tuberculosis

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 5, 2010, Pages 897-900

  Evans, Joanna ^a   Segal, Heidi ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Kanamycin; Ofloxacin; XDR TB

Indexed keywords

ISONIAZID; KANAMYCIN; OFLOXACIN; RIFAMPICIN; BACTERIAL DNA; DNA TOPOISOMERASE (ATP HYDROLYSING); TUBERCULOSTATIC AGENT;

AGAR GEL ELECTROPHORESIS; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MUTATION; CONTROLLED STUDY; MULTIDRUG RESISTANCE; MULTIPLEX POLYMERASE CHAIN REACTION; MUTATIONAL ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; ALLELE; BACTERIAL GENE; COMPARATIVE STUDY; DRUG EFFECT; EVALUATION; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; GENETICS; GENOTYPE; HUMAN; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; POLYMERASE CHAIN REACTION; RNA GENE;

ALLELES; ANTITUBERCULAR AGENTS; DNA GYRASE; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; GENES, BACTERIAL; GENES, RRNA; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION;

EID: 77953706921     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq047     Document Type: Article

References (10)

1. WHO. Anti-Tuberculosis Drug Resistance in the World: Report No. 4. 2008. http://whqlibdoc.who.int/hq/2008/WHO_HTM_TB_2008.394_eng. pdf (13 January 2010, date last accessed).
2. Takiff HE, Salazar L, Guerrero C et al. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob Agents Chemother 1994; 38: 773-80.
3. Maus CE, Plikaytis BB, Shinnick TM. Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2005; 49: 3192-7.
4. Evans J, Stead MC, Nicol MP et al. Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa. J Antimicrob Chemother 2009; 63:11-6.
5. WHO. Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Antituberculosis Drugs. Geneva: WHO, 2008. WHO/HTM/TB/2008.392.
6. Mlambo CK, Warren RM, Poswa X et al. Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa. Int J Tuberc Lung Dis 2008; 12: 99-104.
7. Mokrousov I, Otten T, Manicheva O et al. Molecular characterization of ooxacin-resistant Mycobacterium tuberculosis strains from Russia. Antimicrob Agents Chemother 2008; 52: 2937-9.
8. Escribano I, Rodríguez JC, Llorca B et al. Importance of the efux pump systems in the resistance of Mycobabacterium tuberculosis to uoroquinolones and linezolid. Chemother 2007; 53: 397-401.
9. Zaunbrecher MA, Sikes RD Jr, Metchock B et al. Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 2009; 106: 20004-9.
10. Yu S, Girotto S, Lee C et al. Reduced afnity for isoniazid in the S315T mutant of Mycobacterium tuberculosis KatG is a key factor in antibiotic resistance. J Biol Chem 2003; 278: 14769-75.